Licensing
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.
Showing 37–48 of 59 articles
Fierce Pharma Asia: Key Insights on Recent Deals and Trends
Pfizer and Innovent's $10B Cancer Drug Deal: Key Insights
Trump's Pharma Deals Under Scrutiny: Insights and Implications
Trump's Drug-Pricing Deals: New Product Launches on the Horizon
CordenPharma Expands Production Capacity with New CDMO Deal
AstraZeneca's Breast Cancer Pill and ADAP Deal Insights
Eli Lilly's New Gene Therapy and Strategic Deals: Insights for Investors
SK bioscience's $260M Deal for Varicella Vaccine Production in Colombia
Impact of COINS Act Expansion on China Biotech Licensing
GOP Lawmaker Urges Action on China Biotech Deals
Merck-Kelun ADC's Strategic Wins and Takeda's Antitrust Loss
Incyte's Strategic AI Partnerships: Implications for Pharma